Clinical Trial

Impact of Trans-catheter Aortic Valve Implantation on Renal Function

Study acronym: TAVIKOD
Recruiting
View on ClinicalTrials.gov →
Summary
Both contrast-induced acute kidney injury (AKI) and pre-existing chronic kidney disease are associated with an increased mortality risk in patients requiring aortic valve replacement. Nonetheless, the direct haemodynamic impact of the aortic barrage (i.e. pre-renal mechanism) on renal function compromising and its reversibility in patients undergoing trans-catheter aortic valve implantation (TAVI) is unknown. This registry aims to evaluate the effect of severe aortic stenosis removal on the risk of contrast-induced acute renal injury (CI-AKI) during TAVI procedures and on renal function evolution
Trial Details
NCT Number NCT07626710
Lead Sponsor Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Conditions Aortic Valve Stenosis, Chronic Kidney Diseases, Renal Failure Acute Chronic
Enrollment 1,000 participants
Start Date 2024-08-30
Primary Completion 2028-08-30 (estimated)
Study Completion 2033-08-30 (estimated)
Updated on ClinicalTrials.gov 2026-06-04